Personal Information

Y Venkat Reddy

Managing Director

Education & Training

  • Medical Education: :
    MS in Regulatory Affairs from North-eastern University,
  • Experience :
    20+ years


Mr. Venkat Reddy Yelma, a first generation, entrepreneur MS in Regulatory Affairs (Drugs, Biologics & Devices) from Northeastern University, USA has over 20+ years of experience in various companies. He is a value-driven biopharma executive with proven expertise in drug development, organizational leadership & successful in developing and implementing global regulatory affairs in US and Singapore based firms – ImClone, Bayer & Merck (Formerly Schering-Plough).

Mr Reddy has worked over 15 years in USA and Singapore and is one of the founders of GeneSys. Mr Reddy was involved in the development of several complex Biologics (e.g. recombinant proteins, monoclonal antibodies) from R&D, Clinical stage (Phase-I/II/III) through marketing applications in the USA, EU, Japan and Rest of the World. The estimated overall global sales from the products involved in approval is greater than $10 Billion. Mr. Reddy has provided significant leadership in proactive planning, preparation, execution of technical and regulatory strategies complementing overall drug-development. Proven track record in the development of biologics, define and implements global regulatory strategies; work with cross-functional project teams to execute the agreed-upon strategies; interacts with regulatory agencies to negotiate agreements; coordinates the planning and conduct of regulatory agency meetings.

Mr. Reddy has an impeccable experience of over 20 years in Biotech industry and proven track record to Build, Inspire and Deliver high value biopharma products globally. Mr. Venkat Reddy is the strategic backbone of the company and responsible for overall business, operations and management of the organization.

At GeneSys, he is leading the development and execution of company’s long-term strategy and formulates a clear vision & direction and building and sustaining a business model that optimizes financing, market, and operational strategies. Develop multiple products in-house from bench to market approval.